Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia

NCT00876798 is registered in ClinicalTrials.gov with CardioKine Inc. as lead sponsor.

NCT NCT00876798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00876798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia
Lead sponsor
CardioKine Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2009
Completion date
Not reported
Enrollment
206 (actual)
Sites
90

Conditions

As the registry lists them; a condition with its own page is linked.

euvolemic hyponatremia